Stock overview
Halozyme Therapeutics Inc.
Explore the company, reported ownership, price history, and available source evidence.
HALOZYME THERAPEUTICS INC (HALO) is a healthcare or biotechnology equity security tracked from 13F filings.
- Last close
- $95.80
- · HALO
- Tracked holders
- 3 funds
- Latest available 13F per fund
HALO · USD
Price
Close · Nov 18, 2026
- Range low
- $95.80
- Range high
- $131.18
- Observations
- 23
- Session date
- Nov 18, 2026
Oct 19, 2026–Nov 18, 2026. Regular market hours only. Historical prices are unadjusted; splits and other corporate actions can affect comparisons.
Investor Popularity
Rows are narrowed by movement, fund type, and position size.
| Fund | Move | Value | Weight |
|---|---|---|---|
| Gotham Asset Management largest tracked holder Q3 2026 · filed Nov 16, 2026 · SEC filing | +11% 26'Q3 | $90,802,786 | 0.18% |
| Renaissance Technologies position history Q3 2026 · filed Nov 12, 2026 · SEC filing | +25% 26'Q3 | $66,031,454 | 0.09% |
|
Thrive Capital
position history
Q2 2026
· filed Aug 14, 2026
· SEC filing 1 SEC filing 2 |
+23% 26'Q2 | $4,960,440 | 0.11% |
SEC Forms 4/5
Insiders
Financials
Official-source analysis
AI Earnings Report
No published AI Earnings Report yet
We publish a cited AI Earnings Report after an eligible official earnings filing is accepted and passes validation.
Options market